Skip to main content
UniHealth

Doctor search

Louis Chang, MD

Ophthalmology · Mountain View

NPI 1538295720

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
34
9 carriers
Offices
3

Offices

3 locations · Northern California Retina Vitreous Associates Medical Group, Inc. · 7 clinicians in this group

Looking this up.

Hospitals listed: Good Samaritan Hospital · Mills-Peninsula Medical Center. That is not proof they admit you there this week.

Plans that list them

34 plans · 9 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chang’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

34 of 34 plans

Plans whose provider directory lists this clinician
Alignment Health Advantage PPO (PPO)Alignment Health PlanListedOct 3, 2026
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Silicon (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Sutter Advantage +More (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health smartHMO (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health the ONE (HMO)Alignment Health PlanListedOct 3, 2026
Anthem Full Dual Advantage Aligned (HMO D-SNP)Anthem Blue CrossListedOct 3, 2026
Anthem Medicare Advantage (HMO-POS)Anthem Blue CrossListedOct 3, 2026
Anthem Prime (HMO-POS)Anthem Blue Cross Partnership PlanListedOct 3, 2026
Astiva Health C-SNP WOW - NorCal (HMO C-SNP)Astiva HealthListedSep 27, 2026
Astiva Health Premier Plan - NorCal (HMO)Astiva HealthListedSep 27, 2026
Astiva Health Savings Plan - NorCal (HMO)Astiva HealthListedSep 27, 2026
Blue Shield Inspire (HMO)Blue Shield of CaliforniaListedAug 26, 2026
Central Health Classic Care Plan III (HMO)Central Health Medicare PlanListedAug 15, 2026
Central Health Dual Access Plan (HMO D-SNP)Central Health Medicare PlanListedAug 15, 2026
Central Health Embrace Care Plan (HMO C-SNP)Central Health Medicare PlanListed, may be out of dateSep 15, 2025
Central Health Embrace Choice Plan (HMO C-SNP)Central Health Medicare PlanListedAug 15, 2026
Central Health Valor Care Plan (HMO)Central Health Medicare PlanListedAug 15, 2026
Imperial Courage Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Dynamic Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Senior Value (HMO C-SNP)Imperial Health Plan of California, Inc.ListedSep 1, 2026
SCAN Balance (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
SCAN Classic (HMO)SCAN Health PlanListedOct 3, 2026
SCAN MyChoice (HMO)SCAN Health PlanListedOct 3, 2026
SCAN Strive (HMO C-SNP)SCAN Health PlanListedOct 3, 2026
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

California Medical Board record

Licence A91494 · Current

Licensed to practise in California · since 2013 · expires 2028-06-30 · Washington University School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend it
    Overall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
  • Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
See every measure and the patient survey for Good Samaritan Hospital

Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Good Samaritan Hospital
Clostridium Difficile (C.Diff)Infections0.337BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.75 (0 to 1.67) · 1,340 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.84 (0.54 to 1.14)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths143.59 (98.7 to 188.49) · 98 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.7 · 45 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.1 · 100 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.7 · 270 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths11.3 · 573 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths15.6 · 820 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.5 · 482 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.3 · 3,711 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.12 (0 to 0.3) · 8,866 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.2 (0.01 to 0.38) · 9,051 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths2.65 (0.74 to 4.56) · 1,929 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.8 (0.21 to 3.39) · 670 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.33 (0.88 to 3.78) · 1,836 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths6.73 (0 to 13.46) · 669 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths7.58 (3.96 to 11.19) · 654 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.59 (0.13 to 3.04) · 496 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.27 (0 to 0.87) · 7,373 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4.1 · 152 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections1.08No differentOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.542No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.484No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.565No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits15.8 · 327 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits24.2 · 703 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits61.1 · 289 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits36.3 · 665 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits25.4 · 856 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits19 · 978 casesNoneJul 2023 – Jun 2025
Rate of readmission after hip/knee replacementUnplanned return visits6.3 · 144 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits12.3 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits21.2 · 135 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13.8 (10.1 to 18.6) · 129 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1.2 (0.9 to 1.5) · 531 casesNo differentJan 2024 – Dec 2024

What patients said (704 patients answered, 24% of those asked)

Patient survey stars by topic at Good Samaritan Hospital
Cleanliness3
Nurse communication3
Doctor communication2
Communication about medicines2
Discharge information3
Overall hospital rating2
Quietness1
Recommend hospital3
Share of patients giving the best answer at Good Samaritan Hospital
Room was "always" clean66%
Nurses "always" communicated well75%
Doctors "always" communicated well71%
Staff "always" explained54%
Yes, staff "did" give patients this information83%
Yes, staff "did" give patients information about help after discharge81%
Doctors "always" explained things so they could understand66%
Doctors "always" listened carefully69%
Doctors "always" treated them with courtesy and respect78%
Patients who gave a rating of "9" or "10" (high)63%
Staff "always" explained new medications68%
Nurses "always" explained things so they could understand69%
Nurses "always" listened carefully73%
Nurses "always" treated them with courtesy and respect82%
"Always" quiet at night38%
"YES", patients would definitely recommend the hospital67%
Staff "always" explained possible side effects40%
Yes, staff "did" give patients information about possible symptoms86%
See every measure and the patient survey for Peninsula Medical Center

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Peninsula Medical Center
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.139BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.242BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.21 (0.27 to 2.15) · 1,258 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.81 (0.51 to 1.1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths155.44 (112.67 to 198.21) · 90 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.5 · 32 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.1 · 82 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths10 · 188 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9 · 473 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths14.8 · 342 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths9.4 · 485 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.9 · 3,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.2 (0 to 0.4) · 6,904 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.21 (0.02 to 0.4) · 7,052 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.41 (1.43 to 5.39) · 1,695 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.72 (0.17 to 3.28) · 665 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.11 (0.66 to 3.56) · 1,545 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths7.1 (1.3 to 12.9) · 670 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.96 (2.63 to 9.29) · 653 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.15 to 3.08) · 418 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.14 (0 to 0.78) · 5,539 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.7 · 192 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.215No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.263No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.74No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits14.3 · 300 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits19 · 702 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits1.2 · 207 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-13.6 · 531 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits24.3 · 343 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits18.1 · 449 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits4.5 (2.8 to 7) · 85 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits9.6 (6.7 to 13.7) · 85 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.7 · 189 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits11 · 45 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20.6 · 117 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13 (9.7 to 17.2) · 584 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.9 (0.7 to 1.2) · 764 casesNo differentJan 2024 – Dec 2024

What patients said (523 patients answered, 27% of those asked)

Patient survey stars by topic at Peninsula Medical Center
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness3
Recommend hospital5
Share of patients giving the best answer at Peninsula Medical Center
Room was "always" clean76%
Nurses "always" communicated well81%
Doctors "always" communicated well80%
Staff "always" explained58%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge87%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully79%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)75%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night54%
"YES", patients would definitely recommend the hospital78%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$2,333,151

Medicare paid this office $2,333,151 for 660 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Injection, aflibercept, 1 mg186$1,315,157None
Injection, faricimab-svoa, 0.1 mg40$407,046None
Injection of drug into eye245$152,495$116
Injection, ranibizumab, 0.1 mg33$129,261None
Imaging of retina612$92,106$41
See all 15 services
Every Original Medicare service billed
Injection, aflibercept, 1 mg186$1,315,157None
Injection, faricimab-svoa, 0.1 mg40$407,046None
Injection of drug into eye245$152,495$116
Injection, ranibizumab, 0.1 mg33$129,261None
Imaging of retina612$92,106$41
Short return visit (20+ min)397$84,861$86
Established patient complete exam of visual system314$35,515$112
Established patient problem focused exam of visual system195$26,047$87
Return visit (30+ min)123$18,836$121
Exam of retinal blood vessels using a special camera after injection of a dye86$15,585$169
New patient complete exam of visual system94$13,135$140
New patient visit (45+ min)60$8,892$148
Photography of the retina65$3,151$35
2d ultrasound scan of eye tissue and structures32$2,035$47
Extended exam of the back part of the eye with retinal drawing15$313$21

Procedures Medicare counted

Procedure volume Medicare published
Cataract surgery1-10None

Who their Medicare patients are

660 Original Medicare patients in 2024. Average age 79 · Under 65 4% · 85 and older 28% · Women 61% · Also on Medicaid 25% · Health risk score 1.50. Above the middle of the specialty; the typical ophthalmology clinician is at 1.16.

Conditions among them: High blood pressure 75% · Diabetes 35% · Chronic kidney disease 29% · Coronary heart disease 24% · Atrial fibrillation 19% · Heart failure 18% · Cancer 16% · COPD 12% · Depression 12% · Dementia 7% · Stroke 7%.

The office billed $7,132,893, Medicare allowed $2,974,130 and paid $2,333,151; for 23,664 services of 32 kinds; $1,862,009 of it was for drugs given in the office and $471,142 for care.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
202466023,664791.50$7,132,893$2,333,151
202358814,851781.40$6,545,004$2,245,636
20225518,322781.40$5,717,681$2,018,967
20216289,735781.43$6,364,104$2,376,868
202059710,228781.59$6,273,139$2,352,351
201967010,452781.51$5,758,987$2,193,566
20186858,649771.52$4,204,388$1,634,293
20176087,553771.63$3,208,058$1,302,463
20165545,985771.52$1,971,726$973,574
20155285,964771.51$1,949,751$1,023,790
20144084,348771.34$1,352,953$771,153
20135833,053781.38$1,313,511$569,852

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 17 services

Original Medicare services billed in 2023
Injection, aflibercept, 1 mg182$1,433,171None
Injection, ranibizumab, 0.1 mg43$222,145None
Injection, faricimab-svoa, 0.1 mg23$177,090None
Injection of drug into eye230$144,099$111
Established patient problem focused exam of visual system383$86,030$84
Imaging of retina530$79,310$39
Established patient complete exam of visual system225$24,694$110
New patient complete exam of visual system113$15,144$134
Exam of retinal blood vessels using a special camera after injection of a dye78$12,094$136
Short return visit (20+ min)95$9,600$87
New patient visit (45+ min)41$6,221$152
Compounded drug, not otherwise classified16$5,470None
Return visit (30+ min)43$5,011$104
Short return visit62$3,997$56
Photography of the retina64$2,900$34
2d ultrasound scan of eye tissue and structures20$1,274$47
Extended exam of the back part of the eye with retinal drawing11$263$24

2022: 15 services

Original Medicare services billed in 2022
Injection, aflibercept, 1 mg155$1,302,059None
Injection, ranibizumab, 0.1 mg54$349,394None
Injection of drug into eye223$124,878$108
Established patient problem focused exam of visual system372$89,732$82
Imaging of retina473$67,247$38
Established patient complete exam of visual system242$27,226$112
Exam of retinal blood vessels using a special camera after injection of a dye66$9,858$119
New patient complete exam of visual system60$8,534$142
Compounded drug, not otherwise classified22$5,916None
Photography of the retina97$5,138$34
New patient visit (45+ min)38$4,702$124
Destruction of leaking blood vessels of retina using laser11$4,309$331
Return visit (30+ min)23$2,460$107
2d ultrasound scan of eye tissue and structures23$1,429$41
Extended exam of the back part of the eye with retinal drawing14$331$24

2021: 14 services

Original Medicare services billed in 2021
Injection, aflibercept, 1 mg138$1,319,141None
Injection, ranibizumab, 0.1 mg85$630,489None
Injection of drug into eye241$144,308$111
Established patient problem focused exam of visual system314$92,549$86
Imaging of retina538$75,669$40
Established patient complete exam of visual system333$45,498$104
New patient visit (45+ min)132$18,637$141
Exam of retinal blood vessels using a special camera after injection of a dye72$10,541$121
Compounded drug, not otherwise classified29$8,046None
Photocoagulation treatment to prevent detachment of retina12$5,919$493
Photography of the retina125$5,736$36
2d ultrasound scan of eye tissue and structures24$2,758$49
Extended exam of the back part of the eye with retinal drawing35$789$22
Extended exam of the back part of the eye with optic nerve drawing19$290$15

2020: 14 services

Original Medicare services billed in 2020
Injection, aflibercept, 1 mg111$1,175,954None
Injection, ranibizumab, 0.1 mg100$727,894None
Injection of drug into eye237$126,826$96
Established patient problem focused exam of visual system279$105,801$84
Imaging of retina509$73,463$39
Established patient complete exam of visual system359$57,085$106
New patient visit (45+ min)144$19,635$136
Compounded drug, not otherwise classified34$10,458None
Exam of retinal blood vessels using a special camera after injection of a dye87$10,289$105
Photography of the retina138$7,944$42
Destruction of leaking blood vessels of retina using laser12$6,405$320
2d ultrasound scan of eye tissue and structures27$2,130$52
Extended exam of the back part of the eye with retinal drawing58$1,474$23
Extended exam of the back part of the eye with optic nerve drawing51$784$15

2019: 14 services

Original Medicare services billed in 2019
Injection, aflibercept, 1 mg99$885,992None
Injection, ranibizumab, 0.1 mg119$837,625None
Injection of drug into eye242$121,535$96
Established patient problem focused exam of visual system323$114,559$84
Imaging of retina558$77,012$39
Established patient complete exam of visual system397$64,650$105
New patient visit (45+ min)164$21,227$129
Exam of retinal blood vessels using a special camera after injection of a dye113$11,933$93
Compounded drug, not otherwise classified56$9,699None
Destruction of leaking blood vessels of retina using laser17$8,672$334
Photography of the retina152$8,531$47
Examination of eye by ophthalmoscope with retinal drawing111$5,253$27
Examination of eye by ophthalmoscope with retinal drawing54$2,423$25
2d ultrasound scan of eye tissue and structures26$1,827$57

2018: 15 services

Original Medicare services billed in 2018
Injection, ranibizumab, 0.1 mg80$652,980None
Injection, aflibercept, 1 mg55$557,485None
Established patient problem focused exam of visual system300$96,912$80
Injection of drug into eye198$96,727$95
Imaging of retina564$71,053$39
Established patient complete exam of visual system394$61,065$110
New patient visit (45+ min)192$24,659$128
Compounded drug, not otherwise classified69$16,254None
Exam of retinal blood vessels using a special camera after injection of a dye78$6,785$85
Destruction of leaking blood vessels of retina using laser14$5,922$312
Photography of the retina105$5,737$52
Examination of eye by ophthalmoscope with retinal drawing119$5,205$26
2d ultrasound scan of eye tissue and structures31$3,400$74
Examination of eye by ophthalmoscope with retinal drawing29$1,064$24
Imaging of optic nerve19$490$26

2017: 15 services

Original Medicare services billed in 2017
Injection, ranibizumab, 0.1 mg63$485,126None
Injection, aflibercept, 1 mg41$408,309None
Established patient problem focused exam of visual system322$96,439$78
Injection of drug into eye181$87,342$95
Imaging of retina506$63,874$38
Established patient complete exam of visual system303$40,615$103
New patient visit (45+ min)195$26,442$136
Compounded drug, not otherwise classified84$21,347None
Exam of retinal blood vessels using a special camera after injection of a dye99$7,682$77
Photography of the retina110$7,423$67
Destruction of leaking blood vessels of retina using laser16$5,899$295
2d ultrasound scan of eye tissue and structures42$5,076$85
Examination of eye by ophthalmoscope with retinal drawing96$3,967$25
Examination of eye by ophthalmoscope with retinal drawing24$838$22
Imaging of optic nerve15$476$32

2016: 14 services

Original Medicare services billed in 2016
Injection, ranibizumab, 0.1 mg56$331,810None
Injection, aflibercept, 1 mg25$276,733None
Established patient problem focused exam of visual system308$82,505$79
Injection of drug into eye157$62,628$92
Imaging of retina450$57,100$42
New patient visit (45+ min)226$31,108$138
Established patient complete exam of visual system212$25,718$99
Exam of retinal blood vessels using a special camera after injection of a dye103$21,355$103
Compounded drug, not otherwise classified80$15,043None
Photography of the retina116$8,733$70
2d ultrasound scan of eye tissue and structures33$6,488$90
Destruction of leaking blood vessels of retina using laser16$6,120$322
Examination of eye by ophthalmoscope with retinal drawing94$3,679$26
Examination of eye by ophthalmoscope with retinal drawing25$811$24

2015: 15 services

Original Medicare services billed in 2015
Injection, ranibizumab, 0.1 mg60$418,130None
Injection, aflibercept, 1 mg22$240,990None
Established patient problem focused exam of visual system289$66,288$81
Injection of drug into eye133$63,301$99
Imaging of retina390$47,769$43
New patient visit (45+ min)241$35,122$146
Exam of retinal blood vessels using a special camera after injection of a dye140$28,429$103
Established patient complete exam of visual system205$26,033$101
Destruction of leaking blood vessels of retina using laser11$15,011$938
Photography of the retina155$10,749$69
Unclassified biologics48$8,070None
Examination of eye by ophthalmoscope with retinal drawing158$7,256$26
2d ultrasound scan of eye tissue and structures46$7,188$91
Examination of eye by ophthalmoscope with retinal drawing79$2,925$23
Compounded Drug, Not Otherwise Classified30$2,511$55

2014: 14 services

Original Medicare services billed in 2014
Injection, ranibizumab, 0.1 mg44$362,340None
Injection, aflibercept, 1 mg14$127,464None
Injection of drug into eye108$47,586$95
Established patient complete exam of visual system206$34,960$109
Imaging of retina273$31,562$43
New patient visit (45+ min)213$29,911$140
Exam of retinal blood vessels using a special camera after injection of a dye140$29,141$103
Established patient problem focused exam of visual system123$14,826$81
Destruction of leaking blood vessels of retina using laser11$12,478$960
Photography of the retina152$11,001$70
Unclassified biologics56$9,080None
2d ultrasound scan of eye tissue and structures45$6,382$90
Examination of eye by ophthalmoscope with retinal drawing153$5,818$26
Examination of eye by ophthalmoscope with retinal drawing52$1,572$23

2013: 15 services

Original Medicare services billed in 2013
Injection, aflibercept, 1 mg38$193,746None
Injection, ranibizumab, 0.1 mg45$163,838None
Injection of drug into eye119$28,736$94
Imaging of retina381$25,359$39
Established patient problem focused exam of visual system253$24,897$69
New patient visit (45+ min)150$22,061$147
Established patient complete exam of visual system176$17,698$98
Exam of retinal blood vessels using a special camera after injection of a dye72$15,034$107
Removal of eye fluid (vitreous) between lens and retina16$14,158$885
Photography of the retina84$5,983$70
2d ultrasound scan of eye tissue and structures30$4,064$90
Unclassified biologics36$4,042None
Examination of eye by ophthalmoscope with retinal drawing119$3,497$29
New patient complete exam of visual system23$2,490$108
Examination of eye by ophthalmoscope with retinal drawing46$1,346$27

Medicaid work

$597,294 in 2024

Medicaid paid $597,294 for 2,706 billed services this clinician did in 2024, up to 63 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2024
Aflibercept injection409$392,665
Intravitreal injection of a pharmacologic agent (separate procedure)647$157,839
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina1,011$22,969
Short return visit (20+ min)514$19,925
Injection, bevacizumab, 10 mg32$2,109
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient64$1,629
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST29$157
Medicaid work by year
20242,706763$597,294
20233,581759$1,049,281
20223,694851$1,099,537
20213,339859$922,656
20202,996752$1,050,746
20192,742746$888,497
20182,285544$1,158,444
See the largest Medicaid services in earlier years

2023

Largest Medicaid services in 2023
Aflibercept injection619$772,583
Intravitreal injection of a pharmacologic agent (separate procedure)846$219,568
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina1,162$27,028
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient786$23,396
Injection, bevacizumab, 10 mg98$3,979
FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT44$2,601
Short return visit (20+ min)26$126

2022

Largest Medicaid services in 2022
Aflibercept injection672$848,113
Intravitreal injection of a pharmacologic agent (separate procedure)852$196,982
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient882$23,826
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina989$20,599
FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT170$6,613
FLUORESCEIN ANGRPH W/MULTIFRAME IMG I&R UNI/BI39$1,724
Injection, bevacizumab, 10 mg66$1,017
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST24$663

2021

Largest Medicaid services in 2021
Aflibercept injection583$706,876
Intravitreal injection of a pharmacologic agent (separate procedure)798$169,389
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient799$22,444
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina993$20,062
FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT37$1,975
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST71$1,151
Injection, bevacizumab, 10 mg46$641
New patient visit (45+ min)12$118

2020

Largest Medicaid services in 2020
Aflibercept injection490$805,748
Intravitreal injection of a pharmacologic agent (separate procedure)760$200,732
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient742$22,704
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina871$19,946
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST102$1,244
Injection, bevacizumab, 10 mg15$235
FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT16$137

2019

Largest Medicaid services in 2019
Aflibercept injection316$656,686
Intravitreal injection of a pharmacologic agent (separate procedure)702$182,079
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina850$25,342
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient750$22,896
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST92$1,054
Injection, bevacizumab, 10 mg18$293
FUNDUS PHOTOGRAPHY W/INTERPRETATION & REPORT14$148

2018

Largest Medicaid services in 2018
Aflibercept injection282$936,229
Intravitreal injection of a pharmacologic agent (separate procedure)561$175,743
Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina760$24,130
Ophthalmological services: medical examination and evaluation, with initiation or continuation of diagnostic and treatment program; intermediate, established patient669$22,205
OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST13$136

Drugs they prescribed that Part D paid

$8,660

Pharmacies billed $8,660 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 217) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.

127 generic and 90 brand-name prescriptions · $8,660 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Prednisolone Acetate63$2,435$39
Ketorolac Tromethamine34$922$27
Diclofenac31$296$10
Neomycin-Polymyxin-Dexameth25$265$11
Brimonidine16$134$8

Year by year

Part D prescribing by year
2024217640% (0)41%$8,660
2023165480% (0)32%$7,588
2022166510% (0)31%$7,527
2021172560% (0)38%$7,799
202024165None55%$26,163
201926166None46%$17,658
201819457None44%$13,013
2017189636% (12)47%$12,363
2016180688% (15)44%$12,494
201518560None49%$13,270
2014132568% (11)40%$8,642
201320560None58%$15,684

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 4 drugs

Part D drugs prescribed in 2023
Prednisolone Acetate30$1,160$39
Ketorolac Tromethamine44$809$18
Neomycin-Polymyxin-Dexameth33$530$16
Brimonidine12$117$10

2022: 4 drugs

Part D drugs prescribed in 2022
Prednisolone Acetate37$1,665$45
Neomycin-Polymyxin-Dexameth41$593$14
Ketorolac Tromethamine35$511$15
Latanoprost14$436$31

2021: 5 drugs

Part D drugs prescribed in 2021
Prednisolone Acetate37$1,587$43
Neomycin-Polymyxin-Dexameth45$792$18
Timolol Maleate17$398$23
Ketorolac Tromethamine21$286$14
Latanoprost15$270$18

2020: 8 drugs

Part D drugs prescribed in 2020
Azopt23$7,467$325
Prolensa16$4,444$278
Combigan11$3,327$302
Prednisolone Acetate54$1,889$35
Ketorolac Tromethamine29$620$21
Neomycin-Polymyxin-Dexameth24$404$17
Brimonidine12$309$26
Timolol Maleate15$179$12

2019: 7 drugs

Part D drugs prescribed in 2019
Prolensa11$2,945$268
Simbrinza15$2,531$169
Prednisolone Acetate61$2,388$39
Acetazolamide Er16$667$42
Brimonidine11$560$51
Ketorolac Tromethamine31$533$17
Neomycin-Polymyxin-Dexameth29$434$15

2018: 5 drugs

Part D drugs prescribed in 2018
Simbrinza11$1,755$160
Prednisolone Acetate39$1,515$39
Bromfenac12$771$64
Neomycin-Polymyxin-Dexameth31$429$14
Ketorolac Tromethamine22$327$15

2017: 4 drugs

Part D drugs prescribed in 2017
Prednisolone Acetate42$1,906$45
Neomycin-Polymyxin-Dexameth60$934$16
Ketorolac Tromethamine17$311$18
Hydrocodone-Acetaminophen12$49$4

2016: 5 drugs

Part D drugs prescribed in 2016
Nevanac13$2,946$227
Durezol13$1,988$153
Prednisolone Acetate29$1,469$51
Neomycin-Polymyxin-Dexameth64$1,030$16
Hydrocodone-Acetaminophen14$113$8

2015: 2 drugs

Part D drugs prescribed in 2015
Prednisolone Acetate44$2,353$53
Neomycin-Polymyxin-Dexameth56$974$17

2014: 3 drugs

Part D drugs prescribed in 2014
Acetazolamide15$2,093$140
Prednisolone Acetate13$780$60
Neomycin-Polymyxin-Dexameth32$532$17

2013: 5 drugs

Part D drugs prescribed in 2013
Travatan Z18$2,850$158
Combigan18$2,490$138
Alphagan P16$1,408$88
Prednisolone Acetate25$316$13
Pantoprazole13$97$7

Money from drug and device companies

$134 in 2025

Industry payments by year
202511None$134
202433None$89
202335None$261
202224None$179
202112None$145
202011None$22
201959$12,072$12,790

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
MedtronicKyphon Express II Kyphopak Tray$134
1 payment
  • Meals for Kyphon Express II Kyphopak Tray · 2025-10-29 · $134
See the published payment
Every published payment
MedtronicMeals · 2025-10-29Kyphon Express II Kyphopak Tray$134
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)

2024: $89

Payments by company in 2024
Genentech USAVabysmo$30
1 payment
  • Meals for Vabysmo · 2024-03-15 · $30
Astellas Pharma USIzervay$30
1 payment
  • Meals for Izervay · 2024-04-12 · $30
Apellis PharmaceuticalsSyfovre$29
1 payment
  • Meals for Syfovre · 2024-03-29 · $29

2023: $261

Payments by company in 2023
Genentech USAVabysmo$175
2 payments
  • Meals · 2023-11-25 · $149
  • Meals for Vabysmo · 2023-05-12 · $27
Regeneron Healthcare SolutionsEylea$62
2 payments
  • Meals for Eylea · 2023-06-28 · $29
  • Meals for Eylea · 2023-06-28 · $33
DePuy Synthes SalesVivigen Mis Delivery System$24
1 payment
  • Meals for Vivigen Mis Delivery System · 2023-05-11 · $24

2022: $179

Payments by company in 2022
GenentechSusvimo$135
1 payment
  • Meals for Susvimo · 2022-04-19 · $135
Globus MedicalCreo$44
2 payments
  • Travel for Creo · 2022-10-01 · $40
  • Travel for Creo · 2022-09-01 · $4

2021: $145

Payments by company in 2021
Genentech USALucentis$145
2 payments
  • Meals for Lucentis · 2021-08-19 · $124
  • Meals for Lucentis · 2021-06-15 · $21

2020: $22

Payments by company in 2020
Genentech USALucentis$22
1 payment
  • Meals for Lucentis · 2020-01-16 · $22

2019: $12,790

Payments by company in 2019
F. Hoffmann-La Roche AGLucentis$12,072
3 payments
  • Paid to speak or teach for Lucentis · 2019-12-31 · $6,425
  • Paid to speak or teach for Lucentis · 2019-09-30 · $248
  • Paid to speak or teach for Lucentis · 2019-06-30 · $5,400
AllerganNone$417
1 payment
  • Education · 2019-07-14 · $417
GenentechNon-Covered Product$108
2 payments
  • Meals for Non-Covered Product · 2019-10-11 · $59
  • Meals for Lucentis · 2019-01-07 · $50
Hoffmann-La RocheNon-Covered Product$107
1 payment
  • Meals for Non-Covered Product · 2019-03-21 · $107
Genentech USALucentis$86
2 payments
  • Meals · 2019-10-11 · $69
  • Meals for Lucentis · 2019-03-27 · $17

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
F. Hoffmann-La Roche AG · Lucentis Dosing Retreatment · 2020This clinician$2,812

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
100.0 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1538295720
Licence
CA A91494California A91494: Current · expires 2028-06-30
Trained
University of Washington School of Medicine, 2003
Gender
Male
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207W00000X (207W00000X)
Mailing address
1655 Greenfield Ave, #23, Los Angeles, CA, 90025
NPI first listed
2007-02-24
NPI last updated
2007-07-08

This is when the NPI record was last certified, not a medical board exam.